-+ 0.00%
-+ 0.00%
-+ 0.00%

Enliven Therapeutics; Chief Medical Officer Helen Louise Collins disposes of 40,000 common shares valued at $1,404,024

Reuters·03/27/2026 20:58:03

Please log in to view news